Jun 08, 2023
129:127
For every 127 shares held, investors received 129. The price per share adjusted from $171.00 to $168.35.
The split itself did not change the total investment value.
Handa Pharmaceuticals Inc (TPEX:6620) operates in the Pharmaceuticals: major industry.
Handa Pharmaceuticals Inc company overviewHanda Pharmaceuticals Inc's most recent stock split was on June 8, 2023. It was a 129-for-127 forward split, so shareholders received 129 shares for every 127 they held.
Handa Pharmaceuticals Inc (TPEX:6620) has split its stock 4 times: a 1013-for-1000 split on April 26, 2019, a 664-for-661 split on July 19, 2021, a 547-for-543 split on June 14, 2022, and a 129-for-127 split on June 8, 2023.
Handa Pharmaceuticals Inc has split its stock 4 times. This history records 4 forward splits between April 26, 2019 and June 8, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Handa Pharmaceuticals Inc's 129-for-127 split on June 8, 2023, every 127 shares became 129 shares.
Handa Pharmaceuticals Inc has not announced a new split in our records. Its most recent split was on June 8, 2023, 3 years ago. Companies announce splits in advance, and any new TPEX:6620 split will appear on this page.
Already premium?